Cholestech Corp. Says `Razor & Razor Blades' Business Model Key To Ranking Among Bay Area's 150 Fastest Growing Public Companies.Business Editors & Health/Medical Writers HAYWARD, Calif.--(BW HealthWire)--June 1, 2000 Cholestech Corporation (Nasdaq:CTEC CTEC Course and Teacher Evaluation Council (Northwestern University, Office of the Register) CTEC Certified Technical Education Center CTEC Certified Technical Education Center (Microsoft) ) said last week's listing of the company among the San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden Business Times 150 Fastest Growing Public Companies is attributable to building its diagnostic equipment business around the traditional "razor and razor blades ra·zor·blade also ra·zor blade n. A thin sharp-edged piece of steel that can be fitted into a razor. razor blade n → hoja de afeitar razor blade " business model. Cholestech's L.D.X(R) System, the "razor" introduced in 1991, is the most widely available, easy-to-use diagnostic product for screening and monitoring blood cholesterol, blood sugar, and liver function outside of the clinical laboratory. "The test basically provides the same information just as reliably and far more quickly than that available through hospital and clinical labs. Our system was demonstrated very effectively last Sunday Sunday: see Sabbath; week. on ABC's Today Show in the Prevention magazine segment. Over the past year, sales of single-use diagnostic cassettes (the `razor blade') increased 32%. Over the last nine years, the Years, The the seven decades of Eleanor Pargiter’s life. [Br. Lit.: Benét, 1109] See : Time Company has shipped enough single-use cassettes to test 12 million individuals in 35 countries around the world," said Warren E. Pinckert II, Cholestech's president and chief executive officer. Leveraging its position in the diagnostic equipment marketplace, the company acquired HealthNet, Inc. in January 2000, forming the basis of the Company's new WellCheck business. WellCheck has conducted field screenings in pilot programs with WalMart, Walgreen's, CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file. Drug Stores, and in screening programs at selected PGA (1) (Professional Graphics Adapter) An early IBM PC display standard for 3D processing with 640x480x256 resolution. It was not widely used. (2) (Programmable Gate Array) See gate array and FPGA. and Senior PGA tournaments. The new WellCheck.com website, which will enable individuals to monitor and share information with health care providers via the Internet Internet Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the , is scheduled to be unveiled this summer. "Unlike the many all-purpose health-oriented websites that have been struggling, WellCheck.com is focusing specifically on the conditions, personal information, and information resources (1) The data and information assets of an organization, department or unit. See data administration. (2) Another name for the Information Systems (IS) or Information Technology (IT) department. See IT. that the users of Cholestech's diagnostic products and WellCheck testing services require. By enabling health care providers and pharmaceutical companies to engage subscribers by way of WellCheck.com, we will be providing a continuous information loop that will add value for all of the parties involved in cardiac risk management," Pinckert said. About Cholestech: Cholestech is committed to helping people successfully improve their health. Working together, the Cholestech business units of Diagnostic Products, WellCheck(TM), and WellCheck.com can provide simple, accessible, and reliable personal health information to health care practitioners and consumers in over 35 countries around the world. By offering efficient and economic diagnostic screening for cholesterol, blood sugar, and liver function, Cholestech hopes to help more people understand whether or not they face potentially serious health risks. Therapeutic monitoring options using the Cholestech L.D.X(R) System can help patients monitor their progress as they work with their health care provider to reduce their risk of cardiovascular cardiovascular /car·dio·vas·cu·lar/ (-vas´ku-ler) pertaining to the heart and blood vessels. car·di·o·vas·cu·lar adj. Abbr. and other diseases. Working together with health care providers, Cholestech's goal is to ultimately enable people to lead longer, healthier, and more active lives. More information can be found at the company's web site: www.cholestech.com. Statements in this press release other than historical fact, including statements regarding the launch of the Company's WellCheck.com website or the results of potential future strategic objectives, are forward looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Actual results may be affected by additional factors set forth in the Company's Securities and Exchange Commission filings including the Company's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended March 26, 1999. Note to Editors: Cholestech L.D.X and WellCheck(TM) are registered trademarks of Cholestech Corporation. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion